微博
加入微博一起分享新鲜事
登录
|
注册
140
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial https://icostatistics.no/publication/goll-long-term-2019/
请登录并选择要私信的好友
300
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial https://icostatistics.no/publication/goll-long-term-2019/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候